Analysts Set Mersana Therapeutics, Inc. (NASDAQ:MRSN) Price Target at $4.25
Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six brokerages that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. The […]
Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six brokerages that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. The […]
